Cristina Berastegui

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Determinants of Baseline Lung Allograft Dysfunction and its Long-term Impact on Pulmonary Function After Bilateral Lung Transplantation.

Determinants of Baseline Lung Allograft Dysfunction and its Long-term Impact on Pulmonary Function After Bilateral Lung Transplantation.

Journal: Transplantation

Published: June 23, 2026

Diagnostic value of galactomannan in tracheobronchial aspirate for Aspergillus infection in lung transplant recipients (the GALACTBAS study).

Diagnostic value of galactomannan in tracheobronchial aspirate for Aspergillus infection in lung transplant recipients (the GALACTBAS study).

Journal: Journal of clinical microbiology

Published: April 30, 2026

Breakthrough Mold Infections During Long-term Nebulized Liposomal Amphotericin B Prophylaxis in Lung Transplant Recipients: A Single-center Cohort (NEBULA Study).

Breakthrough Mold Infections During Long-term Nebulized Liposomal Amphotericin B Prophylaxis in Lung Transplant Recipients: A Single-center Cohort (NEBULA Study).

Journal: Transplantation

Published: April 08, 2026

Marked clinical and haemodynamic improvement with sotatercept in severe refractory pulmonary arterial hypertension associated with corrected complex congenital heart disease.

Marked clinical and haemodynamic improvement with sotatercept in severe refractory pulmonary arterial hypertension associated with corrected complex congenital heart disease.

Journal: Respiratory medicine case reports

Published: January 22, 2026

Experience with isavuconazole in lung transplant recipients with Aspergillus isolation in respiratory tract specimens: A multicenter, observational study.

Experience with isavuconazole in lung transplant recipients with Aspergillus isolation in respiratory tract specimens: A multicenter, observational study.

Journal: JHLT open

Published: December 04, 2025

Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study.

Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study.

Journal: The Journal of infection

Published: November 02, 2025

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Published: October 30, 2025

Change in Antinuclear Antibodies After Lung Transplantation in Patients with Systemic Sclerosis.

Change in Antinuclear Antibodies After Lung Transplantation in Patients with Systemic Sclerosis.

Journal: Journal of clinical medicine

Published: October 21, 2025

From resistance to response: Bacteriophages in multidrug-resistant Mycobacterium abscessus after lung transplantation.

From resistance to response: Bacteriophages in multidrug-resistant Mycobacterium abscessus after lung transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 29, 2025

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Published: March 13, 2025

Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trial.

Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trial.

Journal: The Lancet regional health. Europe

Published: August 29, 2024

Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation.

Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation.

Journal: Frontiers in immunology

Published: June 07, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026